administered to reduce the drug's cost, remains to be determined. This case demonstrates that a short-term regimen of erythropoietin and iron supplementation may allow high-dose chemotherapy to be offered to those individuals unwilling to accept blood products.
Chronic myelogenous leukemia in Hodgkin's disease: Immunofluorescence of cells
β Scribed by William R. Swaim; Harold E. Windschitl; Alfred Doscherholmen; Rufus O. Bankole; Henry A. Bates
- Publisher
- John Wiley and Sons
- Year
- 1971
- Tongue
- English
- Weight
- 363 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Circulating blood plasma contains proteinaseβdegraded forms of thrombomodulin that are soluble. We quantitatively assayed the plasma levels of thrombomodulin in 15 patients with chronic myelogenous leukemia (CML) in chronic phase by method of an enzymelinked immunosorbent assay using a
We studied telomere length in the peripheral blood leukocyte samples of a large group of patients with chronic myelogenous leukemia (CML) by Southern blot hybridization using the (TTAGGG)4 probe. The average telomere length expressed as the peak telomere repeat array (TRA) of the peripheral blood sa